Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT [Phase 1, Phase 2]
This record summarizes ongoing Phase 1 and Phase 2 clinical trials evaluating prehabilitation strategies for ovarian cancer (including epith…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers [Phase 2]
A Phase 2 study investigating the use of FAPI-PET imaging for initial screening of cholangiocarcinoma and pancreatic adenocarcinoma, status …
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery [Phase 1, Phase 2]
A Phase 1/2 trial of panitumumab-IRDye800 in pancreatic adenocarcinoma patients undergoing surgery is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma [NA]
The study investigates whether GATA6 expression can predict response to peri-operative chemotherapy in resectable pancreatic cancer, with th…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer [Phase 2]
Phase 2 study of zolbetuximab (IMAB362) in adults with pancreatic cancer is active but not currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
A Mayo Clinic-sponsored clinical trial update recruiting to collect medical information and tissue samples from patients with pancreatic can…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial evaluating TR-002 for advanced unresectable or metastatic solid tumors and unresectable or metastatic pancreatic ad…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: FAZA PET/MRI Pancreas [NA]
A FAZA PET/MRI imaging study for pancreatic cancer that is unresectable or locally advanced is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating nab-paclitaxel plus cisplatin and gemcitabine in combination with Tumor Treating Fields for metastatic p…
-
CLINICAL_TRIALS other · 2026-02-24Clinical Trial Update: Switch Maintenance in Pancreatic [Phase 1, Phase 2]
A Phase 1/2 trial in pancreatic cancer evaluating switch maintenance has been suspended.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. [EARLY_Phase 1]
An early-phase exploratory clinical study is evaluating Claudin18.2-targeted Activated Dendritic Cells and Claudin18.2-targeted CAR-T therap…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types [Phase 1, Phase 2]
This update reports a Phase 1/2 trial of atezolizumab plus tivozanib in several immunologically cold tumor types, with the study currently s…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating risk-adapted adjuvant chemotherapy guided by tumor stage after neoadjuvant mFOLFIRINOX in patien…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) [Phase 1, Phase 2]
This clinical trial update describes the PREOPANC-5 study evaluating neoadjuvant triple therapy for localized or borderline resectable pancr…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation [Phase 2]
This is a Phase 2 clinical trial update evaluating HRS-4642 in combination with Nimotuzumab and chemotherapy for borderline resectable pancr…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma [Phase 1]
Phase 1 clinical trial update for padeliporfin vascular-targeted photodynamic therapy in locally advanced unresectable pancreatic adenocarci…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.
This clinical trial investigates whether transcriptome-based OncoTreat/Oncotarget profiling and patient-derived organoid testing can predict…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. [Phase 1, Phase 2]
A Phase 1/2 trial to evaluate the safety and efficacy of XER-001 (amifostine delivered nasoduodenally) in combination with stereotactic body…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer [Phase 3]
A Phase 3 clinical trial update evaluating the use of standard chemotherapy before and after surgery for resectable pancreatic cancer is cur…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: ZN-c3 + Gemcitabine in Pancreatic Cancer [Phase 2]
Phase 2 trial update on the combination of ZN-c3 with gemcitabine for pancreatic cancer, with the study currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma. [NA]
Completed a clinical trial evaluating the use of circulating tumor cells for diagnosing pancreatic adenocarcinoma.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC) [Phase 1]
Phase 1 clinical trial evaluating safety and toxicity of SBRT followed by intratumoral PCX12 immunotherapy for locally advanced pancreatic a…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating photoradiation with verteporfin to enhance the immunologic activity of pembrolizumab in unresectable locally advanc…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma [Phase 1]
An ongoing Phase 1 trial evaluating OMTX705 in combination with gemcitabine/nab-paclitaxel and tislelizumab for advanced/metastatic pancreat…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
Terminated clinical trial evaluating the clinical utility of selected circulating tumor DNA assays in patients with advanced malignancies, s…